Will Tesaro Be The Focus Of The Next Biotech Bidding War?

Tesaro (NASDAQ: TSRO) is the latest biotech to see rumors swirl of potential mergers and acquisitions. On the heels of launching Zejula earlier this year, the company could fetch as much as $10 billion in a deal, according to industry watchers. Whether this company gets sold, and at what price, is anyone's guess, but given the company's run by Lonnie Moulder, a proven leader with one successful deal already under his belt, it wouldn't shock me if Tesaro's on the block.Tesaro's two commercial-stage drugs are Varubi and Zejula, and both of them arguably have nine-figure sales potential.IMAGE SOURCE: GETTY IMAGES.Continue reading

Topics:  tesaro nasdaq   tsro is   lonnie moulder   tesaro   varubi   source   images   zejula   biotech   company   deal   
BING NEWS:
  • Fortress Biotech’s Q3 2024 Earnings and FDA Milestone
    Fortress Biotech Inc ( (FBIO) ) has released its Q3 earnings. Here is a breakdown of the information Fortress Biotech Inc presented to its ...
    11/14/2024 - 8:09 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News